Changes in the Atherogenic Risk Factor Profile According to Degree of Weight Loss

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 2004 Apr 23

PMID 15102630

Citations 89

Authors

T Reinehr

W Andler

Affiliations

Soon will be listed here.

Abstract

Background: The atherogenic risk factor profile in obese subjects is characterised by hypertension, reduced high density lipoprotein (HDL) cholesterol, increased low density lipoprotein (LDL) cholesterol and triglycerides, and insulin resistance.

Aims: To examine the amount of weight reduction required to improve the atherogenic profile.

Methods: Changes of systolic and diastolic blood pressure, HDL and LDL cholesterol, triglycerides, and insulin resistance, based on the HOMA model over a one year period were studied in obese children, who attended the intervention programme "Obeldicks". The children were divided into four groups according to the change in body mass index standard deviation score (SDS-BMI): group I, increase in SDS-BMI; group II, decrease in SDS-BMI <0.25; group III, decrease in SDS-BMI > or =0.25-<0.5; group IV, decrease in SDS-BMI > or =0.5.

Results: A total of 130 children (mean age 10.7 years, range 4-15; mean SDS-BMI 2.5, range 2.0-4.0) were studied. The four groups did not differ in age, gender, or degree of overweight (SDS-BMI). An increasing SDS-BMI (group I: n = 20) was followed by a significant increase in insulin resistance (HOMA). Systolic and diastolic blood pressure, LDL cholesterol, triglycerides, and insulin resistance (HOMA) decreased significantly while HDL cholesterol increased significantly in group IV (n = 37). LDL cholesterol also decreased significantly in group III (n = 40); there was no significant change of the other parameters in groups I, II, and III.

Conclusion: Over a time period of one year increasing weight in obese children leads to an increase in insulin resistance. Weight loss is associated with an improvement in the atherogenic profile and in insulin resistance, but only if the SDS-BMI decreases by at least 0.5 over a one year period.

Citing Articles

Family Shopping Basket Intervention: A Strategy to Reduce Obesity in Prepubertal Children.

Escartin R, de Peray B, Couto Y, Martinez-Mejias A, Corripio R J Clin Med. 2025; 14(1.

PMID: 39797309 PMC: 11720977. DOI: 10.3390/jcm14010227.

Effectiveness of Smartphone App for the Treatment of Pediatric Obesity: A Randomized Controlled Trial.

Umano G, Masino M, Cirillo G, Rondinelli G, Massa F, Mangoni di Santo Stefano G Children (Basel). 2024; 11(10).

PMID: 39457143 PMC: 11505602. DOI: 10.3390/children11101178.

Effectiveness of utilizing step-monitoring devices to prevent and treat obesity in children and adolescents: A systematic review and meta-analysis.

Wang W, Ruan H, Shen Y, Cheng J, Sun W, Huang C Digit Health. 2024; 10:20552076241272589.

PMID: 39148809 PMC: 11325471. DOI: 10.1177/20552076241272589.

Current and future state of pharmacological management of pediatric obesity.

Fox C, Kelly A, Reilly J, Theis-Mahon N, Raatz S Int J Obes (Lond). 2024; .

PMID: 38321079 DOI: 10.1038/s41366-024-01465-y.

Long-term effects of 12-month integrated weight-loss programme for children with excess body weight- who benefits most?.

Szczyrska J, Brzezinski M, Szlagatys-Sidorkiewicz A Front Endocrinol (Lausanne). 2023; 14:1221343.

PMID: 38027174 PMC: 10656687. DOI: 10.3389/fendo.2023.1221343.

References

Csabi G, Torok K, Jeges S, Molnar D . Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000; 159(1-2):91-4. DOI: 10.1007/pl00013812. View

Sazawal S, Black R, Jalla S, Mazumdar S, Sinha A, Bhan M . Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics. 1998; 102(1 Pt 1):1-5. DOI: 10.1542/peds.102.1.1. View

Cole T, Bellizzi M, Flegal K, Dietz W . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320(7244):1240-3. PMC: 27365. DOI: 10.1136/bmj.320.7244.1240. View

Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4):683-9. DOI: 10.2337/diacare.24.4.683. View

Kiess W, Reich A, Muller G, Meyer K, Galler A, Bennek J . Clinical aspects of obesity in childhood and adolescence--diagnosis, treatment and prevention. Int J Obes Relat Metab Disord. 2001; 25 Suppl 1:S75-9. DOI: 10.1038/sj.ijo.0801704. View

Facchini F, Hua N, Abbasi F, Reaven G . Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001; 86(8):3574-8. DOI: 10.1210/jcem.86.8.7763. View

Landmann E, Gortner L, Reiss I, Weller E, Tegtmeyer F . Protein content and biophysical properties of tracheal aspirates form neonates with respiratory failure. Klin Padiatr. 2002; 214(1):1-7. DOI: 10.1055/s-2002-19859. View

Sung R, Yu C, Chang S, Mo S, Woo K, Lam C . Effects of dietary intervention and strength training on blood lipid level in obese children. Arch Dis Child. 2002; 86(6):407-10. PMC: 1763008. DOI: 10.1136/adc.86.6.407. View

Ebbeling C, Pawlak D, Ludwig D . Childhood obesity: public-health crisis, common sense cure. Lancet. 2002; 360(9331):473-82. DOI: 10.1016/S0140-6736(02)09678-2. View

10.

de Jongh S, Ose L, Szamosi T, Gagne C, Lambert M, Scott R . Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation. 2002; 106(17):2231-7. DOI: 10.1161/01.cir.0000035247.42888.82. View

11.

Kraus W, Houmard J, Duscha B, Knetzger K, Wharton M, McCartney J . Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002; 347(19):1483-92. DOI: 10.1056/NEJMoa020194. View

12.

Wang J, Staessen J . Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials. J Clin Hypertens (Greenwich). 2003; 5(1):66-75. PMC: 8101815. DOI: 10.1111/j.1524-6175.2003.01307.x. View

13.

Dirisamer A, Hachemian N, Bucek R, Wolf F, Reiter M, Widhalm K . The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr. 2003; 162(6):421-5. DOI: 10.1007/s00431-003-1181-3. View

14.

Reinehr T, Kersting M, Alexy U, Andler W . Long-term follow-up of overweight children: after training, after a single consultation session, and without treatment. J Pediatr Gastroenterol Nutr. 2003; 37(1):72-4. DOI: 10.1097/00005176-200307000-00013. View

15.

Reinehr T, Brylak K, Alexy U, Kersting M, Andler W . Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord. 2003; 27(9):1087-92. DOI: 10.1038/sj.ijo.0802368. View

16.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

17.

Rossner S, Bjorvell H . Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis. 1987; 64(2-3):125-30. DOI: 10.1016/0021-9150(87)90237-1. View

18.

Reaven G, Hoffman B . A role for insulin in the aetiology and course of hypertension?. Lancet. 1987; 2(8556):435-7. DOI: 10.1016/s0140-6736(87)90968-8. View

19.

Epstein L, Kuller L, Wing R, Valoski A, McCurley J . The effect of weight control on lipid changes in obese children. Am J Dis Child. 1989; 143(4):454-7. DOI: 10.1001/archpedi.1989.02150160080016. View

20.

MOSSBERG H . 40-year follow-up of overweight children. Lancet. 1989; 2(8661):491-3. DOI: 10.1016/s0140-6736(89)92098-9. View